Howard E. Greene Jr., Director at AMYLIN PHARMACEUTICALS INC (AMLN), sold 3,700 shares at $49.50 ($183K) on 2007-09-04, disclosed to the SEC on 2007-09-06.
Scheduled sale ($183k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TNDM | SELL | 2018-11-07 | $861K | — | Filing → |
| TNDM | BUY | 2018-02-13 | $100K | — | Filing → |
| TNDM | SELL | 2015-08-04 | $254K | — | Filing → |